Literature DB >> 24812155

Amelioration of streptozotocin-induced diabetic nephropathy by melatonin, quercetin, and resveratrol in rats.

H Elbe1, N Vardi2, M Esrefoglu3, B Ates4, S Yologlu5, C Taskapan6.   

Abstract

The role of oxygen radicals are known for the pathogenesis of kidney damage. The aim of the present study was to investigate the antioxidative effects of melatonin, quercetin, and resveratrol on streptozotocin (STZ)-induced diabetic nephropathy in rats. A total of 35 male Wistar rats were divided into 5 groups as follows: control, diabetes mellitus (DM), DM + melatonin, DM + quercetin, and DM + resveratrol. All the injections started on the same day of single-dose STZ injection and continued for 30 days. At the end of this period, kidneys were removed and processed for routine histological procedures. Biochemical parameters and morphological changes were examined. In DM group, blood glucose levels were significantly increased, whereas body weights were decreased compared with the control group. Significant increases in blood urea nitrogen and tissue malondialdehyde (MDA) levels and decreases in superoxide dismutase and catalase activities were detected in DM group. Administration of melatonin, quercetin, and resveratrol significantly reduced these values. Melatonin was more efficient in reducing MDA levels than other antioxidants (p < 0.05). STZ-induced histopathological alterations including epithelial desquamation, swelling, intracytoplasmic vacuolization, brush border loss and peritubular infiltration. Additionally, basement membrane thickening and sclerotic changes were observed in glomerulus. Transforming growth factor-β1 positive cells were also increased. Melatonin, quercetin, and resveratrol significantly reduced these histopathological changes. Our results indicate that melatonin, quercetin, and resveratrol might be helpful in reducing diabetes-induced renal damage.
© The Author(s) 2014.

Entities:  

Keywords:  Streptozotocin; TGF-β1; diabetic nephropathy; melatonin; quercetin; resveratrol

Mesh:

Substances:

Year:  2014        PMID: 24812155     DOI: 10.1177/0960327114531995

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  27 in total

1.  Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy.

Authors:  Ömer Hazman; Mehmet Fatih Bozkurt
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

2.  Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.

Authors:  Chao-Sheng Lo; Yixuan Shi; Isabelle Chenier; Anindya Ghosh; Chin-Han Wu; Jean-Francois Cailhier; Jean Ethier; Jean-Baptiste Lattouf; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Diabetes       Date:  2017-04-19       Impact factor: 9.461

Review 3.  Sirtuin 1: A Target for Kidney Diseases.

Authors:  Lili Kong; Hao Wu; Wenhua Zhou; Manyu Luo; Yi Tan; Lining Miao; Lu Cai
Journal:  Mol Med       Date:  2015-01-12       Impact factor: 6.354

4.  Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression.

Authors:  Mona K Tawfik; Mohammed M Keshawy; Samy Makary
Journal:  Mol Biol Rep       Date:  2021-08-24       Impact factor: 2.316

Review 5.  Renal Protective Effects of Melatonin in Animal Models of Diabetes Mellitus-Related Kidney Damage: A Systematic Review and Meta-Analysis.

Authors:  Qian Luo; Yuzi Cai; Qihan Zhao; Yuhua Jiang; Lei Tian; Yuning Liu; Wei Jing Liu
Journal:  J Diabetes Res       Date:  2022-06-14       Impact factor: 4.061

6.  Antidiabetic Potency, Antioxidant Effects, and Mode of Actions of Citrus reticulata Fruit Peel Hydroethanolic Extract, Hesperidin, and Quercetin in Nicotinamide/Streptozotocin-Induced Wistar Diabetic Rats.

Authors:  Alaa M Ali; Mohamed Abdel Gabbar; Sanaa M Abdel-Twab; Eman M Fahmy; Hossam Ebaid; Ibrahim M Alhazza; Osama M Ahmed
Journal:  Oxid Med Cell Longev       Date:  2020-06-20       Impact factor: 6.543

Review 7.  Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus.

Authors:  Fareha Wajid; Raju Poolacherla; Fatiha Kabir Mim; Amna Bangash; Ian H Rutkofsky
Journal:  J Diabetes Metab Disord       Date:  2020-07-21

8.  Melatonin Promotes Heterotopic Ossification Through Regulation of Endothelial-Mesenchymal Transition in Injured Achilles Tendons in Rats.

Authors:  Jie Zhang; Jiajun Tang; Jie Liu; Bo Yan; Bin Yan; Minjun Huang; Zhongmin Zhang; Liang Wang
Journal:  Front Cell Dev Biol       Date:  2021-02-11

Review 9.  Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.

Authors:  Qichao Hu; Caiyan Qu; Xiaolin Xiao; Wenwen Zhang; Yinxiao Jiang; Zhao Wu; Dan Song; Xi Peng; Xiao Ma; YanLing Zhao
Journal:  Chin Med       Date:  2021-08-07       Impact factor: 5.455

10.  Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy.

Authors:  Isabele B S Gomes; Marcella L Porto; Maria Carmen L F S Santos; Bianca P Campagnaro; Thiago M C Pereira; Silvana S Meyrelles; Elisardo C Vasquez
Journal:  Lipids Health Dis       Date:  2014-12-06       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.